Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 19.80% vs -5.57% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -34.88% vs -42.35% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 6.61% vs 52.60% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -14.09% vs 24.20% in Mar 2024
Compare Profit and Loss Results of Aarey Drugs
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
473.00
120.00
353.00
294.17%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
473.00
120.00
353.00
294.17%
Expenditure (Ex Depriciation)
Stock Adjustments
-10.00
-1.00
-9.00
-900.00%
Raw Materials Consumed
472.00
46.00
426.00
926.09%
Power & Fuel Cost
0.00
4.00
-4.00
-100.00%
Employee Cost
0.00
41.00
-41.00
-100.00%
Operating Expenses
1.00
4.00
-3.00
-75.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
3.00
5.00
-2.00
-40.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
7.00
-7.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
471.00
123.00
348.00
282.93%
Operating Profit (PBDIT) excl Other Income
2.00
-2.00
4.00
200.00%
Other Income
9.00
3.00
6.00
200.00%
Operating Profit (PBDIT)
12.00
1.00
11.00
1,100.00%
Interest
4.00
3.00
1.00
33.33%
Profit before Depriciation and Tax
8.00
-1.00
9.00
900.00%
Depreciation
1.00
8.00
-7.00
-87.50%
Profit Before Taxation & Exceptional Items
6.00
-10.00
16.00
160.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
-33.00
39.00
118.18%
Provision for Tax
2.00
0.00
2.00
0%
Profit After Tax
4.00
-32.00
36.00
112.50%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
53.00
-112.00
165.00
147.32%
Profit Available for appropriations
57.00
-144.00
201.00
139.58%
Appropriations
57.00
-144.00
201.00
139.58%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.42
-9.05
10.47
115.69%
Profit And Loss - Net Sales
Net Sales 473.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 19.80% vs -5.57% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -34.88% vs -42.35% in Mar 2024
Profit And Loss - Interest
Interest 4.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.61% vs 52.60% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 4.02 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -14.09% vs 24.20% in Mar 2024






